Skip to main content
. 2023 Apr 26;13(3):583–595. doi: 10.3390/clinpract13030053

Table 2.

Detailed information and characteristics of included studies.

Studies Country Mean Age (Y) Female/
Male
Sample Size (n) Duration (Y) Intervention Outcomes Follow-Up
HBOT con HBOT con HBOT con HBOT con HBOT con
Efrati 2015 [19] Israel 50.4 ± 10.9 48.1 ± 11.1 NA NA 24 26 6.75 ± 5.9 6.2 ± 5.1 hyperbaric oxygen therapy at 2.0 ATA.
40 daily sessions, 5 days/week, 90 min each.
no treatment TPC (of 18),Pain threshold, FIQ, SF-36 2M
Hadanny 2018 [24] Israel 48.3 ± 10.6 43.1 ± 10.6 30 0 15 15 NA NA hyperbaric oxygen therapy at 2.0 ATA and psychological therapy.
60 daily sessions, 5 days a week. 90 min each.
psychological therapy WPI, TPC (of 18), FIQ, SF-36 3M
Yildiz 2004 [12] Turkey 40.46 ± 4.79 39.88 ± 4.71 35 15 26 24 4 ± 1.1 hyperbaric oxygen therapy at 2.4 ATA.
15 sessions, one session per day for 5 days of the week, 90 min each.
breathed air at
1 ATA for 90 min
TPC, 6MWT, VAS, Pressure pain threshold 3W
Izquierdo-Alventosa 2020 [25] Spain NA NA 33 0 17 16 NA NA hyperbaric oxygen therapy at 1.45 ATA.
40 sessions, five sessions per week, 90 min each.
usual medication VAS, pressure pain threshold 10W

HBOT = Hyperbaric Oxygen Therapy, con = control, NA = not available, Y = years, M = months, W = weeks, ATA = atmosphere absolute, WPI = Widespread pain index, FIQ = Fibromyalgia functional impairment, 6MWT = Fatigue following the completion of the 6-min walking test, VAS = visual analog scale.